MASH - Metabolic Dysfunction-Associated Steatohepatitis research hub
4 indexed studies · 4 currently recruiting
- recruitingNA
Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)
This study looks into how a sugar called fructose might affect people with MASH, a liver condition. Researchers will compare fructose to another sugar, glucose, over four weeks to see if it causes more inflammation or affects liver fat in people with MASH compared to those with less severe liver issues or healthy people.
United Kingdom - recruitingPHASE1, PHASE2
Study of TGM-312-SC01 in Healthy Participants and Adults With MASH
This study is testing a new medicine, TGM-312-SC01, for liver condition called MASH. We want to see if it's safe, what dose works best, and how it affects the body in both healthy people and those with MASH.
United Kingdom - recruitingPHASE3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
This study is testing a new medicine, efruxifermin, for people with a serious liver condition called NASH/MASH cirrhosis. It's to see if the medicine helps improve liver health in those with scarring that hasn't yet caused severe problems.
United States · Argentina · Australia - recruitingPHASE2
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
This study looks at a medicine called Resmetirom for people who've had a liver transplant and now have a liver condition called MASH. It wants to see if the medicine can help improve their liver health.
United States · Canada